Flu Vaccine for All: A Critical Look at the Evidence
Eric A. Biondi, MD, MS; C. Andrew Aligne, MD, MPH
| Disclosures December 21, 2015
WHEN VACCINATION BECAME ROUTINE
Vaccine proponents felt that the failure of the vaccine was explained by the immunization campaign being too little, too late. As a result, in 1960, national health experts recommended, for the first time, routine annual vaccination, with emphasis on high-risk groups, including those over the age of 65 years and individuals with chronic illness. By the early 1960s, routine influenza vaccination was generally adopted as a policy, with very little supporting evidence.
After several years of this policy, the CDC decided to evaluate its impact. In 1964,Alexander Langmuir, MD, MPH, then the chief epidemiologist at the CDC, published a paper that “reluctantly concluded that there is little progress to be reported. The severity of the epidemic of 1962-1963…demonstrates the failure to achieve effective control of excess mortality.” The paper questioned whether widespread influenza immunization “should be continued without better evidence to justify the major costs to the general public.” Despite this, annual vaccination campaigns were continued.
In 1968, the CDC finally performed a randomized, double-blind trial to examine the effect of vaccination on morbidity and mortality. The authors concluded that “Despite extensive use of influenza vaccines…attainment of [improved morbidity and mortality] has never been demonstrated.” Nevertheless, flu immunization continued.
In 1976, H1N1 “swine flu” appeared, and a large-scale effort to immunize as many Americans as possible was launched. However, the anticipated levels of disease did not appear, and an epidemic of paralytic Guillain-Barré syndrome in recipients of vaccine led to the program’s cancellation. An analysis in 1977 by the CDC concluded that influenza control had been “generally ineffective” and that statistically valid community trials were needed.
In 1995, a major review from the US Food and Drug Administration acknowledged the ongoing “paucity of randomized trials” and warned about serious methodological flaws in many existing flu vaccine studies.
In 2000, the CDC performed a placebo-controlled trial and found that “vaccination [when compared to placebo] may not provide overall economic benefit in most years.”
Nonetheless, in 2004, the AAP recommended annual influenza immunization for young children, household contacts, and healthcare providers.
Vaccination coverage recommendations continued to expand, and now during every flu season, we watch commercials by retail pharmacies telling us about the importance of getting the flu shot. The fact that the AAP recommends “mandatory” flu vaccination for healthcare providers means that eventually clinicians could be fired for not getting vaccinated.
Summing Up the Data
A 2012 systematic review and meta-analysis examined the efficacy and effectiveness of licensed influenza vaccines in patients with confirmed influenza illness. The authors confirmed that the original “recommendation to vaccinate the elderly was made without data for vaccine efficacy or effectiveness.” The main message was that we need a better vaccine and better studies to demonstrate its effectiveness.
Despite the lack of high-quality data supporting the value of the flu shot, widespread vaccination policy might still be reasonable if observational studies consistently showed a benefit. However, the observational studies cited by flu shot proponents are frequently flawed.[22-28] In many studies, relevant clinical outcomes are ignored in favor of immunogenicity (ie, the ability to elicit an antibody response). “Influenza-like illness” (ie, cold symptoms) is frequently measured instead of serious outcomes, such as pneumonia or death. When these more serious outcomes are examined, there is often a failure to control for healthy user bias—the propensity for healthier people to do such things as receive annual check-ups, eat healthier foods, and get the flu shot. So, although it’s true that people who get flu shots live longer, it may have nothing to do with actually getting the flu shot.
A 2005 study of a 33-season, national data set attempted to reconcile the reduced all-cause morbidity and mortality found in some observational studies of influenza vaccination with the fact that “national influenza mortality rates among seniors increased in the 1980s and 1990s as the senior vaccination coverage quadrupled.”In this study, the authors conclude that:
“[Our] estimates, which provide the best available national estimates of the fraction of all winter deaths that are specifically attributable to influenza, show that the observational studies must overstate the mortality benefits of the vaccine…[even during two pandemic seasons] the estimated influenza-related mortality was probably very close to what would have occurred had no vaccine been available.”
The rationale for flu immunization as a national health priority is that influenza is a disease with serious complications, such as pneumonia, hospitalization, and death.[5,13,28] If the reason for influenza vaccination is that flu is such a serious disease, then the relevant outcomes are whether vaccination improves morbidity and mortality from flu. However, after decades of vaccine use, it is hard to detect any public health impact. This is in stark contrast to other routine vaccinations, such as polio andHaemophilus influenzae type b, where introduction of the vaccine led to obvious decline of the disease.
We are pediatricians, and we believe in childhood immunizations. Many vaccines have provided immense public health value. We simply question whether the policy of routine influenza vaccination has outpaced the data supporting its use.
Influenza vaccination now supersedes many other priorities of public health (such as obesity, illiteracy, and high school dropout), and we question whether so much time, effort, and money should be dedicated to flu vaccination while these other national healthcare priorities remain on the back burner.
[ CLOSE WINDOW ]
Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 influenza season. MMWR Morb Mortal Wkly Rep. 2015;64:818-825.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6430a3.htm Accessed September 14, 2015.
Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2015-2016. Pediatrics. 2015;136:792-808.http://pediatrics.aappublications.org/content/early/2015/09/01/peds.2015-2920.full.pdfAccessed September 14, 2015.
Brownlee S, Lenzer J. Does the vaccine matter? The Atlantic. November 2009.http://www.theatlantic.com/doc/200911/brownlee-h1n1 Accessed September 16, 2015.
Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2012;8:CD004879.http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004879.pub4/abstract Accessed September 14, 2015.
Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines to prevent influenza in healthy adults. Cochrane Database Syst Rev. 2014;3:CD001269.http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001269.pub5/abstract;jsessionid=96780A7CC76A9AF58372894444AE3F04.f02t03 Accessed September 14, 2015.
National Archives and Record Administration. The deadly virus.https://www.archives.gov/exhibits/influenza-epidemic/ Accessed September 14, 2015.
Salk Institute for Biological Studies. About Jonas Salk.http://www.salk.edu/about/jonas_salk.html Accessed September 15, 2015.
Members of the Commission on Influenza, Board for the Investigation and Control of influenza and Other Epidemic Diseases in the Army, Preventative Medicine Service, Office of the Surgeon General, Unites States Army. A clinical evaluation of vaccination against influenza (preliminary report). JAMA. 1944;124:982-985.
Francis T, Salk J, Quilligan JJ. Experience with vaccination against influenza in the spring of 1947. Am J Public Health Nations Health. 1947;37:1017-1022.
Influenza pandemics. The History of Vaccines.http://www.historyofvaccines.org/content/articles/influenza-pandemics Accessed September 16, 2015.
Henderson DA, Courtney B, Inglesby TV, Toner E, Nuzzo JB. Public health and medical responses to the 1957-58 influenza pandemic. Biosecur Bioterror. 2009;7:265-273.http://online.liebertpub.com/doi/pdf/10.1089/bsp.2009.0729 Accessed September 16, 2015.
Jensen KE, Dunn FL, Robinson RQ. Influenza, 1957: a variant and the pandemic. Prog Med Virol. 1958;1:165-209. Abstract
Langmuir AD, Henderson DA, Serfling RE. The epidemiological basis for the control of influenza. Am J Public Health Nations Health. 1964;54:563-571.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1254817/ Accessed September 16, 2015.
Schoenbaum SC, Mostow SR, Dowdle WR, Coleman MT, Kaye HS. Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy. Bull World Health Organ. 1969;41:531-535.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427700/pdf/bullwho00220-0191.pdfAccessed September 16, 2015.
Sencer DJ, Millar JD. Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis. 2006;12:29-33. http://wwwnc.cdc.gov/eid/article/12/1/05-1007_article Accessed September 16, 2015.
Dull HB, Bryan JA. Assuring the benefits of immunization in the future: research in the public interest. Bull World Health Organ. 1977;55 (Suppl 2):117-125.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2367076/pdf/bullwho00451-0117.pdfAccessed September 16, 2015.
Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med. 1995;123:518-527. Abstract
Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284:1655-1663. Abstract
American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for influenza immunization in children. Pediatrics. 2004;113:1441-1447.http://pediatrics.aappublications.org/content/113/5/1441.full Accessed September 16, 2015.
American Academy of Pediatrics Committee on Infectious Diseases. Influenza immunization for all health care personnel: keep it mandatory. Pediatrics. 2015;136:809-818.
Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:36-44.Abstract
Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 1998;158:1769-1776.Abstract
Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med. 1994;121:947-952. Abstract
Patriarca PA, Weber JA, Parker RA, et al. Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol. 1986;124:114-119. Abstract
Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001;184:665-670. Abstract
Hak E, Nordin J, Wei F, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis. 2002;35:370-377. Abstract
Monto AS, Hornbuckle K, Ohmit SE. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am J Epidemiol. 2001;154:155-160. Abstract
Patriarca PA, Weber JA, Parker RA, et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA. 1985;253:1136-1139. Abstract
Simonsen L, Reichert TA, Viboud C, et al. Impact of influenza vaccination of seasonal mortality in the U.S. elderly population. Arch Intern Med. 2005;165:265- 272 Abstract